Skip to content

13F-HR filed by Alta Fundamental Advisers LLC

Alta Fundamental Advisers LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 13 holding rows worth $205,541,805.

Accession
0001641604-23-000003
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 13 entries on the cover page, a total value of $205,541,805 stated on the cover page (in dollars after the unit check, H1), rows summing to $205,541,805 with VALUE read as dollars as filed, 13F file number 028-17211. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALPHA METALLURGICAL RESOUR I020764106COM458,437$75,348,705dollars as filed
LUCKY STRIKE ENTERTAINMENT C10258P102CL A COM3,233,827$37,641,746dollars as filed
USA TODAY CO INC36472T109COM13,146,482$29,579,585dollars as filed
SINCLAIR INC829242956PUT2,124,800$23,798,000dollars as filedput
EXPAND ENERGY CORPORATION COM165167735Stock213,940$17,902,499dollars as filed
THE ODP CORP88337F105COM94,758$4,436,570dollars as filed
ARQ INC00770C101COM2,006,972$3,732,968dollars as filed
EAST RES ACQUISITION CO274681105COM CL A350,000$3,510,500dollars as filed
Indivior PLCG4766E116Common Stock150,000$2,734,500dollars as filed
Milestone Pharmaceuticals Inc59935V107COM897,961$2,559,189dollars as filed
MALLINCKRODT PLCG5890A102COM1,947,093$2,297,570dollars as filed
ORIGIN MATERIALS INC68622D106COM452,000$1,925,520dollars as filed
NEOLEUKIN THERAPEUTICS INC64049K104COM89,702$74,453dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001641604-23-000003this filing2023-08-14acceptance time not in the bulk data set